{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:20:16Z","timestamp":1791501616421,"version":"4.3.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To examine the rate of skin color reporting in randomized controlled trials (RCTs) involving melanoma in the top ten highest dermatology journals by impact factor over the past four decades.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic review of RCTs involving melanoma within the top ten dermatology journals, as determined by impact factor, was conducted from inception to July 10th, 2023. Studies were included if they reviewed the diagnosis and\/or treatment of melanoma, were RCTs, directly involved patients and were written in English. Studies were characterized as positive for reporting skin of color (SOC) if the demographic data in the results or methods sections included any of the following: race, ethnicity, skin of color, Fitzpatrick scale, sunburn tendency, phototype, skin type, or skin tone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Out of 76 studies initially identified, only 49 articles met inclusion criteria. Of these 49 articles, only 24 articles recorded data of skin color from their demographics (49%). Subgroup analysis showed no statistically significant difference in the rate of reporting between studies grouped by decade (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.779) or by study location (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.763).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Darker skin tones can disguise melanotic skin lesions. Less than 50% of RCTs related to melanoma in the top ten international dermatology journals included skin color within their results section to characterize study participants. This has a negative impact on our understanding of this potentially devastating disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00403-025-03793-z","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T08:26:05Z","timestamp":1737015965000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Shades of evidence: a review of skin color reporting in melanoma-related randomized controlled trials"],"prefix":"10.1007","volume":"317","author":[{"given":"Deven P.","family":"Curtis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha L.","family":"Salmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony N.","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine F.","family":"Busby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert T.","family":"Brodell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,16]]},"reference":[{"key":"3793_CR1","doi-asserted-by":"publisher","unstructured":"Bradford PT, Goldstein AM, McMaster ML, Tucker MA (2009) Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986\u20132005. Arch Dermatol 145(4). https:\/\/doi.org\/10.1001\/archdermatol.2008.609","DOI":"10.1001\/archdermatol.2008.609"},{"key":"3793_CR2","unstructured":"American Cancer Society American Cancer Society. Cancer Facts & Figs.\u00a02017\u20132018. Breast Cancer Facts & Figures. Published online 2017"},{"key":"3793_CR3","doi-asserted-by":"publisher","unstructured":"Saginala K, Barsouk A, Aluru JS, Rawla P, Barsouk A (2021) Epidemiology of Melanoma. Med Sci (Basel) 9(4). https:\/\/doi.org\/10.3390\/medsci9040063","DOI":"10.3390\/medsci9040063"},{"key":"3793_CR4","doi-asserted-by":"publisher","unstructured":"Agbai ON, Buster K, Sanchez M et al (2014) Skin cancer and photoprotection in people of color: a review and recommendations for physicians and the public. J Am Acad Dermatol 70(4). https:\/\/doi.org\/10.1016\/j.jaad.2013.11.038","DOI":"10.1016\/j.jaad.2013.11.038"},{"key":"3793_CR5","doi-asserted-by":"publisher","unstructured":"Higgins S, Nazemi A, Chow M, Wysong A (2018) Review of nonmelanoma skin cancer in African americans, hispanics, and asians. Dermatol Surg 44(7). https:\/\/doi.org\/10.1097\/DSS.0000000000001547","DOI":"10.1097\/DSS.0000000000001547"},{"key":"3793_CR6","doi-asserted-by":"publisher","unstructured":"Cress RD, Holly EA (1997) Incidence of cutaneous melanoma among non-hispanic whites, hispanics, asians, and blacks: an analysis of California Cancer Registry Data, 1988-93. Cancer Causes Control 8(2). https:\/\/doi.org\/10.1023\/A:1018432632528","DOI":"10.1023\/A:1018432632528"},{"key":"3793_CR7","doi-asserted-by":"publisher","unstructured":"Qian Y, Johannet P, Sawyers A, Yu J, Osman I, Zhong J (2021) The ongoing racial disparities in melanoma: an analysis of the Surveillance, Epidemiology, and end results database (1975\u20132016). J Am Acad Dermatol 84(6). https:\/\/doi.org\/10.1016\/j.jaad.2020.08.097","DOI":"10.1016\/j.jaad.2020.08.097"},{"key":"3793_CR8","doi-asserted-by":"publisher","unstructured":"Huang K, Fan J, Misra S (2020) Acral Lentiginous Melanoma: incidence and survival in the United States, 2006\u20132015, an analysis of SEER Registry. J Surg Res 251. https:\/\/doi.org\/10.1016\/j.jss.2020.02.010","DOI":"10.1016\/j.jss.2020.02.010"},{"key":"3793_CR9","doi-asserted-by":"publisher","unstructured":"Zheng YJ, Ho C, Lazar A, Ortiz-Urda S (2021) Poor melanoma outcomes and survival in Asian American and Pacific Islander patients. J Am Acad Dermatol 84(6). https:\/\/doi.org\/10.1016\/j.jaad.2020.08.086","DOI":"10.1016\/j.jaad.2020.08.086"},{"issue":"7","key":"3793_CR10","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00403-024-03187-7","volume":"316","author":"NL Salmen","year":"2024","unstructured":"Salmen NL, Curtis DP, Baumann AN, Willets J, Brodell RT (2024) Skin color reporting in basal cell carcinoma-related randomized controlled trials in top dermatology journals: a systematic review. Arch Dermatol Res 316(7):451. https:\/\/doi.org\/10.1007\/s00403-024-03187-7","journal-title":"Arch Dermatol Res"},{"issue":"4","key":"3793_CR11","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00403-024-02843-2","volume":"316","author":"NL Salmen","year":"2024","unstructured":"Salmen NL, Menage K, Baumann AN, Curtis DP, Brodell RT (2024) Skin color reporting in squamous cell carcinoma-related randomized controlled trials in top dermatology journals: a systematic review. Arch Dermatol Res 316(4):115. https:\/\/doi.org\/10.1007\/s00403-024-02843-2","journal-title":"Arch Dermatol Res"},{"issue":"2","key":"3793_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ijwd.2020.12.018","volume":"7","author":"KL Perlman","year":"2021","unstructured":"Perlman KL, Williams NM, Egbeto IA, Gao DX, Siddiquee N, Park JH (2021) Skin of color lacks representation in medical student resources: a cross-sectional study. Int J Women\u2019s Dermatology 7(2):195\u2013196. https:\/\/doi.org\/10.1016\/j.ijwd.2020.12.018","journal-title":"Int J Women\u2019s Dermatology"},{"issue":"3","key":"3793_CR13","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.jaad.2019.12.078","volume":"83","author":"A Fenton","year":"2020","unstructured":"Fenton A, Elliott E, Shahbandi A, Ezenwa E, Morris C, McLawhorn J (2020) Medical students\u2019 ability to diagnose common dermatologic conditions in skin of color. J Am Acad Dermatol 83(3):957\u2013958. https:\/\/doi.org\/10.1016\/j.jaad.2019.12.078","journal-title":"J Am Acad Dermatol"},{"key":"3793_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.06.041","author":"SM Alvarado","year":"2020","unstructured":"Alvarado SM, Feng H (2020) Representation of dark skin images of common dermatologic conditions in educational resources: a cross-sectional analysis. J Am Acad Dermatol. https:\/\/doi.org\/10.1016\/j.jaad.2020.06.041S0190-9622(20)31138\u20135","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"3793_CR15","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ijwd.2021.04.001","volume":"7","author":"BN Wilson","year":"2021","unstructured":"Wilson BN, Sun M, Ashbaugh AG, Ohri S, Yeh C, Murrell DF, Murase JE (2021) Assessment of skin of color and diversity and inclusion content of dermatologic published literature: an analysis and call to action. Int J Women\u2019s Dermatology 7(4):391\u2013397. https:\/\/doi.org\/10.1016\/j.ijwd.2021.04.001","journal-title":"Int J Women\u2019s Dermatology"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-03793-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-025-03793-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-03793-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T08:26:09Z","timestamp":1737015969000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-025-03793-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,16]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3793"],"URL":"https:\/\/doi.org\/10.1007\/s00403-025-03793-z","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,16]]},"assertion":[{"value":"28 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Robert Brodell, M.D. discloses the following potential conflicts of interest: Advisory boards: Novan and Amgen. Research funding: Pfizer, Novartis, and Sanofi. Stock: Veragen, Inc. Deven P. Curtis, Natasha L. Salmen, Anthony N. Baumann, Justine F. Busby and Eliot N. Mostow have no conflicts to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}],"article-number":"262"}}